Should the COVID Vaccine Turn a Big Profit for Big Pharma?

Powered by RedCircle

In the latest news on the coronavirus, Business Casual hosts Daniel Litwin and Tyler Kern analyze Pfizer CEO Albert Bourla’s recent statement about the ethics behind profiting off of a COVID vaccine.

As the government doles out taxpayer dollars to the private sector in the race for a cure, should the resulting vaccine still come at a price to Americans? Bourla is incredulous at the thought, saying “You need to be very fanatic and radical to say something like that right now.”

Whether private companies are getting aid from the government or not, the private sector has provided diagnostic and therapeutic solutions for COVID already. Business Casual explores both sides of the coin of American capitalism in this unprecedented ethical query, discussing…

  1. How “Operation Warp Speed,” has created costly government contracts with private health companies
  2. Why Pfizer has the potential to make over $13 billion in sales if they charge the public
  3. If the private sector finds a solution to COVID, are they accountable to the public’s taxpayer dollars that helped them create a vaccine?
  4. For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.Follow us on social media for the latest updates in B2B!Twitter – @MarketScale
    Facebook – facebook.com/marketscale
    LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

career
Stop Chasing Titles, Build a Career That Matters: A CAO’s Advice on Long-Term Success
March 11, 2026

Career advice in finance and accounting often centers around promotions, titles, and compensation. But in an era where professionals frequently change jobs every few years—the average American worker now stays in a role for less than four years—industries are facing growing talent shortages and reevaluating what long-term career success looks like. The question many…

Read More
Career success
A CEO’s Blueprint for Career Success: Leading with Love to Drive Performance and Culture
March 10, 2026

Leadership right now feels heavier than it did just a few years ago. Teams are stretched, expectations are high, and many employees are quietly disengaged. In fact, Gallup’s 2025 U.S. data shows that only about 31% of employees are actively engaged at work, leaving the majority feeling disconnected or indifferent. For CEOs and senior…

Read More
employer-sponsored apprenticeships
The Degree That Pays You Back: How Employer-Sponsored Apprenticeships Are Rewriting Higher Ed
March 9, 2026

Higher education is under pressure. Over the past few years, public confidence in the value of a four-year degree has declined significantly, with fewer Americans expressing a strong belief that traditional higher education delivers a worthwhile return on investment. At the same time, employers consistently report that graduates lack job-ready skills—particularly the “durable skills”…

Read More
Denial Data
Turning Denial Data Into Action: How Healthcare Organizations Can Fight Back Against Payer Denials
March 5, 2026

Healthcare providers across the U.S. are facing a growing wave of claim denials that is putting pressure on already strained hospital finances. Industry research from the American Hospital Association shows that nearly 15% of medical claims submitted to private payers are initially denied, forcing hospitals and health systems to spend about $19.7 billion annually attempting…

Read More